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Abstract
Dipyridamole (DIP), a coronary vasodilator, presents coactivator activity for a number of antitumor drugs as well as
antioxidant activity in membrane systems. DIP and derivatives interact with membrane systems such as micelles,
phospholipid monolayers and vesicles. The antioxidant effect of DIP and several derivatives upon iron-induced
lipoperoxidation on mitochondria has been reported and a good correlation between the hydrophobicity and their
protective effect was found (M.F. Nepomuceno et al., Free Radic. Biol. Med., 23 (1997) 1046^1054). In the present work an
effort is made to better understand the role of DIP as inhibitor of Fe2-induced lipid peroxidation in mitochondria. At low
concentration, no significant effect on either state IV or state III respiration was found, discarding a possible direct
interaction of DIP or RA-25 with the peripheral benzodiazepine receptor. The association constants for DIP and RA-25 in
mitochondria were estimated, being 0.7 (mg/ml)31 for DIP and 0.2 (mg/ml)31 for RA-25. Oxygen consumption studies in the
presence of FeSO4 showed that the antioxidant effect of DIP or RA-25 did not involved the initial step of Fe2 oxidation.
Our data strongly support the hypothesis that the antioxidant effect of both DIP and RA-25 is related to their partition in the
lipid phase of the mitochondrial membrane and not to a specific interaction with membrane proteins. This protection may be
due either to a direct inhibition of the propagation steps or a scavenger effect on the radicular species that would trigger the
peroxidative process. ß 1999 Elsevier Science B.V. All rights reserved.
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1. Introduction
Dipyridamole (DIP) is a compound that has been
used in coronary heart diseases for its antiplatelet
and vasodilating activities [1,2]. This drug also
showed an antioxidant action as superoxide and hy-
droxyl radical scavenger [3,4], and its chain-breaking
activity places it as an e⁄cient and powerful biolog-
ical antioxidant, as potent as vitamin E [5]. Our data
demonstrated that DIP was a potent antioxidant in
mitochondrial membrane mainly against Fe2 e¡ects
and that its antioxidant action may be associated to
its partition in the lipid bilayer, where lipid peroxi-
dation takes place [6].
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Lipid peroxidation seems to play a major role in
many pathological situations such as ischemia^reper-
fusion [7]. The alterations caused by the lipid perox-
idation may a¡ect the mitochondrial energy trans-
duction related processes [8]. Moreover, the damage
to the membrane may also increase the Fe2 free
concentration [9]. The requirement for Fe2 to in-
duce lipid peroxidation in biological membranes
has long been recognized, although the mechanism
of this process, particularly the identity of the initiat-
ing species, remains controversial [10^15]. Besides
cOH produced through the Fenton reaction, as the
species responsible for the attack to the membrane
[12,14], there is also experimental evidence in the
literature that lipid peroxidation requires as inducers
both Fe2 and Fe3, probably as a dioxygen^iron
complex [14^17], perferryl radical, ferryl radical
[15], or even membrane-bound Fe2 [18].
The interaction of DIP in model membrane sys-
tems has been described by Borissevitch et al. [19],
demonstrating di¡erent a⁄nities of DIP and its de-
rivatives (RA14, RA47 and RA-25) in micelles. Ac-
cording to these studies the hydrophobicity of the
compound correlates with its location in the mem-
brane [19].
On the other hand, the binding of DIP to proteins
such as the benzodiazepine receptor of kidney mito-
chondrial membranes was also described in the liter-
ature [20]. The subunit composition of the mitochon-
drial puri¢ed benzodiazepine receptor complex
apparently includes the voltage-dependent anion
channel (VDAC), the adenine nucleotide carrier
(ADC) and another protein of 18 kDa [21]. It has
been proposed that all three proteins comprise the
activity receptor, with a high a⁄nity for a number
of drugs leading to an increase in the state IV and a
decrease in the state III respiration rates, resulting in
a signi¢cant decrease in the respiratory control ratio
(RC) [22]. The benzodiazepine receptor is also sus-
pected to play some role during hypoosmotic stress
in astrocytes [23], and superoxide radical generation
by phagocytes was found to be markedly sensitive to
benzodiazepine receptor ligands [24]. It is possible
that these compounds would be modulating the ox-
idative response capacity of these cells [25].
The purpose of the present work is to verify
whether the DIP antioxidant action is correlated
with its partition in the mitochondrial membrane,
dependent of a speci¢c protein binding site in the
membrane or simply due to iron chelation. O2 con-
sumption of isolated mitochondria submitted or not
to Fe2 in the presence or in the absence of DIP and
its derivative RA-25 (structural formulae are pre-
sented in Fig. 1) were monitored. To study their
location in the membrane we estimated the associa-
tion constant of DIP and RA-25 to the mitochon-
drial membrane.
Our results strongly support that the partition of
DIP and RA-25 in the mitochondrial membrane ac-
cording to their lipophilicity order is responsible for
the inhibitory e¡ect of DIP on the lipid peroxidation
induced by Fe2. Apparently, the binding to the mi-
tochondrial benzodiazepine receptor, in liver mito-
chondria and under our experimental conditions,
does not occur to a signi¢cant extent. Moreover, a
possible chelation of Fe2 or Fe3 by DIP in our
reaction medium has been discarded, although a di-
rect scavenger e¡ect of DIP on the radicular species
initiating the peroxidative process could also be an
explanation for our data.
2. Materials and methods
2.1. Isolation of mitochondria
Liver mitochondria were isolated from overnight
fasted adult female Wistar rats, according to the pro-
cedure described in the literature [26]. The mitochon-
drial pellet was resuspended in isosmotic bu¡er con-
taining 120 mM KCl and 20 mM Hepes (pH 7.2) to
give a ¢nal protein concentration of 80^100 mg, de-
termined by the biuret method modi¢ed with cholate
addition [27].
2.2. Oxygen uptake measurements
Oxygen consumption was measured using a Clark-
type electrode in a 1.8-ml glass chamber equipped
with a magnetic stirrer and without O2 limitation.
2.3. Standard incubation conditions
The £uorescence experiments were performed in
basic medium containing 120 mM KCl plus 20 mM
Hepes, pH 7.2. Previous incubations were done at
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temperature of 30‡C and for 50 min. Oxygen con-
sumption experiments were performed in basic me-
dium containing 125 mM saccharose, 65 mM KCl,
10 mM Hepes (pH 7.2), 3 mM phosphate, 5 mM
succinate and 5 WM rotenone. FeSO4 was added at
concentrations shown in the ¢gure legends and ta-
bles.
2.4. Determination of association constants
Determination of association constants of the
drugs to the mitochondrial membranes was per-
formed with titration of the drug solution at ¢xed
concentration with variable mitochondrial membrane
protein concentration (from 0.8 to 4.0 mg protein/
ml). Either DIP or RA-25, at a ¢xed concentration,
were added to the medium immediately before the
mitochondrial suspension. Samples were exposed to
a previous incubation or not, followed by a centrifu-
gation at 4000Ug for 15 min. The £uorescence emis-
sion spectra of the supernatant were measured in the
range 425^600 nm with excitation at 405 nm for DIP
and in the range 400^600 nm with excitation at 370
nm for RA-25. Data from the titrations were ana-
lyzed as double reciprocal plots of £uorescence inten-
sity change (vF) at 480 nm for DIP and 430 nm for
RA-25 and membrane concentration (determined as
mg of protein/ml) or by direct ¢tting of the law of
mass action, which gives vF versus membrane con-
centration as previously described [19,28^30].
2.5. DIP and RA-25 binding to mitochondria
Measurement of DIP or RA-25 binding to mito-
chondria was made by titration as described for de-
termination of the association constants. The £uores-
cence intensity of the supernatants decreased with the
increase in the membrane protein concentration. In
order to estimate the amount of drug left in the pellet
(bound to the membrane) the following procedure
was performed. The pellets were immediately placed
in liquid nitrogen [31] and then dissolved in 1 ml of
1% Triton X-100, 10% NaCl and centrifuged at
4000Ug in a Beckman microfuge for 25 min. The
£uorescence of the drug in the supernatants obtained
from this solubilization in the detergent was deter-
mined as already described in the previous section
for the supernatants from the initial titration. The
amount of drug in the pellet was estimated with
standard solutions of drug in the same media in
the absence of mitochondria.
2.6. Estimation of lipid peroxidation
Mitochondria (1 mg protein) were added to 1 ml
of medium immediately followed by DIP or its de-
rivative RA-25 and oxidant addition at di¡erent con-
centrations as indicated in the ¢gures, with subse-
quent incubation for 20 min. After this incubation
period, 0.1 ml of 50 WM butylhydroxytoluene was
added to prevent further lipoperoxidation, and the
samples were treated with 3 ml of 0.04 M H2SO4
and 2 ml of 0.8% thiobarbituric acid (TBA) in 0.1
M NaOH. The samples were boiled for 45 min at
100‡C, and after cooling, 4.0 ml of n-butanol was
added. The mixture was thoroughly mixed and cen-
trifuged at 900Ug for 10 min. The TBA-reactive
substances (TBARS) were determined in the organic
layer with a spectrophotometer at 535 nm. The con-
tent of TBARS was calculated from a standard curve
of 1,1,3,3-tetraetoxypropane as described by Yagi et
al. [32].
3. Results
3.1. DIP and RA-25 do not signi¢cantly alter
mitochondrial respiration
A decrease in the respiratory control (RC) due to
an increase on state IV respiration and a decrease on
state III respiration in mitochondria incubated with
peripheric benzodiazepine receptor ligands [22], in-
cluding DIP [20,22], have previously been reported.
To verify if DIP presented an e¡ect per se on mito-
chondrial respiration, we measured the rate of oxy-
gen consumption by mitochondria energized with
succinate during states IV and III and the RC was
calculated for di¡erent DIP or RA-25 concentra-
tions. The data in Table 1 show that under our ex-
perimental conditions both compounds exhibit a very
slight e¡ect on these parameters, even when used at
low concentrations. Since higher concentrations of
RA-25 are necessary to produce its antioxidant ef-
fect, this derivative caused a higher decrease in RC as
compared to DIP.
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3.2. DIP and RA-25 e¡ect on oxygen consumption by
mitochondria in the presence of FeSO4
When Fe2 is added to respiring mitochondria we
observe bursts of extra oxygen consumption, sepa-
rated by an increasing lag time (vt) as shown in
Fig. 2. Unpublished results from our laboratory in-
dicate that the ¢rst burst of extra O2 consumption
(V1) is related with Fe2 oxidation and that the per-
oxidative damage occurs during the second burst of
extra O2 consumption (V2). The existence of a latent
period, vt, before the lipid peroxidation induced by
iron could start was already described in the litera-
ture [15,18] and is explained as the time needed for
the formation of the initiating species, which depends
on a critical ratio Fe2 :Fe3. Data from Table 2
show that DIP was able to inhibit the second burst
at very low concentration, as already observed when
the peroxidation was followed through TBARS for-
mation [6], without changing V1. An increase in V1
was observed only when very high DIP concentra-
tions (100 WM) and low Fe2 concentrations were
used. It is important to stress that DIP inhibits V2
even when added just before it starts (not shown).
Fig. 1. Structural formulae of dipyridamole and its derivative
RA-25.
Table 1
E¡ect of DIP and RA-25 on oxygen consumption by mitochon-
dria
V4 V3 RC = V3/V4
(natom of O/min per mg protein)
[DIP] WM
0 58 þ 4 212 þ 25 4.0 þ 0.4
2.5 59 þ 5 207 þ 20 3.5 þ 0.4
5.0 62 þ 6 200 þ 22 3.5 þ 0.2
7.5 65 þ 4 198 þ 18 3.2 þ 0.2
10.0 65 þ 4 201 þ 19 3.2 þ 0.2
50.0 101 þ 15 250 þ 20 2.4 þ 0.2
100.0 118 þ 18 262 þ 21 2.1 þ 0.2
[RA-25] WM
0 58 þ 4 212 þ 25 4.0 þ 0.4
50 75 þ 7 233 þ 25 3.0 þ 0.4
100 80 þ 3 235 þ 22 2.7 þ 0.2
250 84 þ 6 233 þ 22 2.7 þ 0.2
500 88 þ 5 218 þ 25 2.5 þ 0.2
Oxygen consumption was measured in the presence of DIP or
RA-25 increasing concentrations. Mitochondria were added in
the basic medium in the presence of succinate. Values are
mean þ S.D. from four experiments.
Table 2
E¡ect of DIP upon the extra oxygen consumption induced by FeII
[DIP] WM V1 [Fe2] WM V2 [Fe2] WM vtmin [Fe2] WM
50 100 200 500 50 100 200 500 50 100 200 500
0 50 þ 6 74 þ 8 111 þ 2 218 þ 10 37 þ 5 47 þ 2 81 þ 8 150 þ 6 6 þ 1 7 þ 1 9 þ 1 11 þ 1
2.5 60 þ 2 72 þ 7 108 þ 5 219 þ 6 ^ ^ ^ ^ ^ ^ ^ ^
5.0 65 þ 5 73 þ 7 110 þ 2 219 þ 8 ^ ^ ^ ^ ^ ^ ^ ^
7.5 62 þ 4 86 þ 4 111 þ 2 223 þ 9 ^ ^ ^ ^ ^ ^ ^ ^
10.0 64 þ 7 91 þ 8 111 þ 5 225 þ 7 ^ ^ ^ ^ ^ ^ ^ ^
50.0 67 þ 7 101 þ 1 141 þ 8 228 þ 3 ^ ^ ^ ^ ^ ^ ^ ^
100.0 104 þ 5 140 þ 11 165 þ 7 240 þ 9 ^ ^ ^ ^ ^ ^ ^ ^
Mitochondrial suspensions (1 mg/ml) were incubated in the presence of increasing DIP concentrations for 1 min before Fe2 addition.
The oxygen consumption was measured as shown in Fig. 2.
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This result suggests that the antioxidant e¡ect of DIP
can not be attributed to inhibition of Fe2 oxidation
but also does not discard the possibility that it pre-
vents either the initiator formation or the initiator
attack, since DIP also eliminates vt.
Similar results were obtained with RA-25, a less
lipophilic derivative than DIP. The protective e¡ect
against the peroxidative damage also occurred but at
much lower extent and at higher concentrations than
DIP (Table 3), in agreement with our previous data
[6].
3.3. Previous incubation of DIP with mitochondria
results in inhibition of CuOOH-induced lipid
peroxidation
DIP was shown to be a powerful antioxidant when
the lipid peroxidation was induced by FeSO4
(IC50 = 1 WM) but was ine¡ective when CuOOH
was the oxidant inductor [6]. In the present work,
the mitochondrial suspensions were previously incu-
bated for 50 min in the presence of increasing con-
centrations of DIP before the CuOOH addition.
CuOOH is a lipophilic compound and generates al-
coxyl radicals in the membrane when cleaved by mi-
tochondrial cytochromes [33], leading to lipid perox-
idation as other organic hydroperoxides [7]. Under
these conditions a partial inhibition (IC50 = 50 WM)
can be observed as shown in Fig. 3. However this
concentration is much higher when compared to the
IC50 obtained when peroxidation was induced by
Fe2.
3.4. Binding constants of DIP and RA-25 to
mitochondria
Titration of a 2 WM solution of DIP with variable
concentrations of mitochondria gave a series of emis-
sion spectra obtained for the supernatants after cen-
trifugation and shown in Fig. 4. It is seen that for
higher membrane concentrations the intensity of £u-
orescence emission decreases, consistent with more
binding of the drug to the membrane and less drug
remaining in the supernatant. These changes in emis-
Fig. 2. E¡ect of FeSO4 on mitochondrial oxygen consumption
measured with a Clark-type polarographic oxygen electrode.
Mitochondrial suspensions (1 mg/ml) were incubated in basic
medium for 1 min and 0.2 mM FeSO4 was added. The ¢gure
shows the extra oxygen consumption in respiring mitochondria.
The ¢rst peak (V1) was attributed to Fe2 oxidation and the
second one (V2) to lipid peroxidation. vt is the lag time be-
tween the two peaks.
Table 3
E¡ect of RA-25 upon the extra oxygen consumption induced by Fe2
[RA-25] WM V1 [Fe2] WM V2 [Fe2] WM vtmin [Fe2] WM
50 100 250 500 50 100 250 500 50 100 250 500
0 50 þ 6 74 þ 8 111 þ 2 218 þ 10 37 þ 7 47 þ 2 80 þ 8 149 þ 7 6 þ 1 7 þ 1 9 þ 1 11 þ 1
50 71 þ 12 92 þ 13 130 þ 12 227 þ 13 31 þ 6 34 þ 3 62 þ 8 83 þ 2 7 þ 1 12 þ 2 10 þ 2 11 þ 1
100 79 þ 12 105 þ 13 146 þ 9 241 þ 2 25 þ 4 29 þ 2 48 þ 1 74 þ 2 8 þ 1 15 þ 2 14 þ 2 13 þ 1
250 86 þ 13 121 þ 13 156 þ 15 243 þ 14 ^ ^ ^ ^ ^ ^ ^ ^
500 92 þ 7 151 þ 13 171 þ 16 246 þ 11 ^ ^ ^ ^ ^ ^ ^ ^
Mitochondrial suspensions (1 mg/ml) were incubated in the presence of increasing RA-25 concentrations for 1 min before FeSO4 addi-
tion. The oxygen consumption was measured as shown in Fig. 2.
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sion spectra were used to estimate the association
constant of DIP to the membrane.
Considering the equilibrium:
DMHD3M 1
where D represents the drug and M the mitochon-
dria, the total £uorescence observed is due to the free
and bound species of D. vF represents the di¡erence
between the £uorescence emission intensity of the
drug at a certain concentration of the mitochondria
(F) and the initial £uorescence intensity (F0), in the
absence of the mitochondrial membrane. This di¡er-
ence (vF) is related to the quantity of the drug asso-
ciated with the mitochondria. In order to obtain
quantitatively the association constants for the bind-
ing of DIP to mitochondria, data for titrations of the
drug with mitochondrial suspension were treated us-
ing the mass-action law and the method of the dou-
ble reciprocal plot [29,30]. This latter treatment is
based on the following equation:
1=vF  1=vFmax  1=vFmaxc1=Kbc1=M 2
A plot of 1/vF as a function of 1/[M] may be used
to ¢nd Kb, the binding constant. The results obtained
for both treatments are listed on Table 4. Some typ-
ical results of these titrations are presented in Fig. 5.
In this ¢gure the binding of DIP to mitochondria at
37‡C and pH 7.0 is shown, while the insert corre-
sponds to the same data presented as a double recip-
rocal plot.
In Table 4 data for binding of DIP to phos-
pholipid vesicles of pure dipalmitoylphosphatidyl-
choline (DPPC) and dipalmitoylphosphatidylglycerol
(DPPG) were also included for comparison [30,34].
The data for binding of the drugs to mitochondria
are presented in (mg/ml)31 since the protein concen-
tration in mg/ml was used in the plots and in the
calculations. In order to transform these data to a
molar basis and compare them to the binding to pure
lipids and micelles, the following procedure was per-
formed. For every lipid component of mitochondrial
membrane an average molecular mass was calculated
assuming a mixture of steroyl and palmitoyl alkyl
chains as well as the unsaturated oleyl, so that for
phosphatidylcholine as an example an average mo-
lecular mass of 760 g/mol was obtained (this is the
average of dipalmitoyl phosphatidylcholine (DPPC),
palmitoyl oleylphosphatidylcholine (POPC), distero-
yl phosphatidylcholine (DSPC) and steroyloleylcho-
line (SOPC) taken with identical proportions). After
this calculation, an average molecular mass for the
Fig. 3. DIP action upon lipid peroxidation induced by CuOOH
with or without previous incubation. Mitochondria (1 mg/ml)
were incubated in basic medium with increasing DIP concentra-
tion for 50 min before CuOOH addition. When no previous in-
cubation was performed, both DIP and CuOOH were added si-
multaneously. The ¢rst column shows the control experiment.
Fig. 4. Fluorescence emission spectra of DIP in supernatants
from mitochondria at di¡erent protein concentrations. Concen-
tration of DIP 2U1036 M. Excitation wavelength 405 nm. Pro-
tein concentration in the range 0.8^4.0 mg/ml.
BBAMEM 77593 3-5-99
M.F. Nepomuceno et al. / Biochimica et Biophysica Acta 1418 (1999) 285^294290
lipids in the outer membrane was obtained using the
known composition and the percentage of lipids rel-
ative to proteins [35].
For the outer membrane the total composition is
52% protein and 48% lipid. So, for 1 mg/ml of total
protein in the sample 0.48/0.52 = 0.92 mg/ml is lipid.
Our calculation gave an average lipid molecular mass
of 756 g/mol for the outer and 861 g/mol for the
inner membrane. Assuming that the binding of DIP
takes place at the outer membrane, 1 mg/ml of pro-
tein corresponds to 1.22 mM of lipid and this can be
used to transform the estimated binding constant to
the outer membrane from 0.5 (mg/ml)31 to 410 M31.
Since in the inner mitochondrial membrane the pro-
portions of protein and lipid are quite di¡erent, 75%
and 25%, respectively, the binding of the drug to the
inner membrane even to a small extent would lead to
a considerable increase of the molar binding constant
to lipids. It is interesting that the binding constants
to mitochondrial membranes estimated above (Table
4) are smaller as compared to pure phospholipids
and micelles [19,28,30,34]. In the case of RA-25 it
Fig. 5. Fitting of £uorescence data for the binding of DIP to mitochondrial membrane using the mass-action law as the change in
emission intensity vF versus mitochondrial suspensions protein concentrations. Concentration of DIP 2U1036 M. Protein concentra-
tions the same as in Fig. 4. Excitation at 405 nm and emission at 480 nm. Inset corresponds to the double reciprocal plot for the
same data.
Fig. 6. Fluorescence emission spectra of DIP in pellets from the
same preparations treated with detergent as described in Section
2. Concentration of DIP 2U1036 M. Excitation wavelength 405
nm. Protein concentration in the range 0.8^4.0 mg/ml.
BBAMEM 77593 3-5-99
M.F. Nepomuceno et al. / Biochimica et Biophysica Acta 1418 (1999) 285^294 291
is also seen that the binding constant is reduced by a
factor of two as compared to DIP while the concen-
tration to achieve 50% inhibition of lipid peroxida-
tion is two orders of magnitude di¡erent, higher for
the more polar derivative RA-25. Our data also show
that, when the mitochondrial suspensions were pre-
incubated with DIP, the binding constant increased
and saturation occurred at lower membrane concen-
trations. In fact, these results showed that DIP per-
meates the membrane and this process is time de-
pendent.
All of the above results show the binding as the
decrease of drug concentration in the supernatant. In
order to assess the amount of drug bound to the
membrane in a more direct way, the same pellet of
the samples used to measure the emission in the
supernatants were dissolved in Triton X-100 deter-
gent in the presence of NaCl, centrifuged, and the
new supernatants were examined for their £uores-
cence emission. The obtained emission spectra are
presented in Fig. 6, and show the increase in £uores-
cence with the increase in membrane protein concen-
tration. In Fig. 7 a plot of the fraction of DIP in the
pellet as a function of membrane protein concentra-
tion is presented. This plot was ¢tted by the mass-
action law, resulting in an association constant of
0.8 þ 0.1 (mg/ml)31 and maximum saturation at
47% of DIP. This means that at 2 micromolar DIP
and an excess of mitochondria, around 47% of the
drug is bound. The value of binding constant is quite
close to the value obtained from the change of £uo-
rescence of the supernatants after incubation of the
drug (Table 4).
4. Discussion
DIP is a potent antioxidant against the Fe2-in-
duced lipid peroxidation in mitochondria [6] and this
e¡ect seems to be related to its high hydrophobicity,
Fig. 7. Fitting of £uorescence data for the binding of DIP to
mitochondrial membrane obtained from measurement of £uo-
rescence spectra of pellet treated with detergent as described in
Section 2. Same data as in Fig. 6.
Table 4
DIP and RA-25 binding constants in mitochondrial membranes and phospholipid vesicles
pH Temp. (‡C) Kb (M31)a Kd (1033 M) Kb (M31)b
DIP
DPPC 7 30 633 þ 22 1.52 þ 0.08 658 þ 35
50 1149 þ 16 0.85 þ 0.02 1176 þ 28
DPPG 7 30 727 þ 81 1.39 þ 0.09 719 þ 46
50 1500 þ 60 0.70 þ 0.02 1428 þ 41
MITOc 7.2 37 0.54 þ 0.04 (443 þ 33)
MITOd 7.2 37 0.42 þ 0.04 (344 þ 33)
MITOe 7.2 37 0.7 þ 0.1 (574 þ 82)
MITOf 7.2 37 0.58 þ 0.05 (475 þ 41)
RA 25
DPPC 7 50 295 þ 70 4.3 þ 1.1 232 þ 59
MITOg 7.2 37 0.25 þ 0.07 (205 þ 57) ^
Binding constants of dipyridamole (DIP) and RA-25 to phospholipids (from [30,34]) calculated by the method of the adouble recipro-
cal and by bthe mass-action law. In mitochondria the concentrations of DIP are c;d2 WM, d5 WM and gthat of RA-25 is 2 WM. Data
were obtained f without incubation and ewith 50 min incubation. Binding constants to mitochondria are in (mg/ml)31 based on total
protein concentration. Values in parentheses correspond to data in M31 calculated as described in the text. Kd is a dissociation con-
stant and Kb an association constant for DPPC and DPPG [34].
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since less hydrophobic derivatives [19,30] are also less
e¡ective in the protection against this peroxidation in
mitochondria [6]. However, it has also been reported
that DIP can bind to the peripheral benzodiazepine
receptor located at the mitochondria outer mem-
brane [20,22], although its a⁄nity for the benzodia-
zepine receptor was found to be ¢ve times lower
(IC50 170 nM) than those reported for other benzo-
diazepine receptor ligands such as RO5-4864 and PK
11195 [22]. The mitochondrial respiratory control is
decreased due to this binding since DIP changes both
rates of oxygen consumption, increasing state IV and
decreasing state III respiration [22]. However, these
data refer to experiments performed with isolated rat
kidney mitochondria, which contain signi¢cantly
higher amounts of benzodiazepine receptors as com-
pared to liver [36]. Under our experimental condi-
tions, working with liver mitochondria, to observe
such alterations much higher concentrations of
both DIP and RA-25 were necessary. The data pre-
sented in Table 1 show that although DIP per se
presents a small e¡ect on the respiratory chain even
at low concentrations, a signi¢cant decrease in RC
values occurs only at DIP or RA-25 concentrations
much higher than those required for the inhibition of
lipid peroxidation (IC50 = 1 WM for DIP protection
[6]). The decrease in RC values at concentrations
above 10 WM could be due to cytotoxic e¡ects result-
ing from the high drug concentration. The concen-
trations of DIP and RA-25 required to cause 50%
inhibition of iron-induced lipid peroxidation di¡er by
two orders of magnitude, being 1 WM and 100 WM,
respectively [6]. These results are corroborated by the
data shown in Table 2, where 2.5 WM DIP com-
pletely abolishes the second peak of extra oxygen
consumption (v2), attributed to the peroxidative
process, whereas an RA-25 concentration 100 times
higher is needed to observe the same e¡ect (Table 3).
The binding constants (Kb) of both compounds, DIP
and RA-25, to the mitochondrial membrane were
calculated (Table 4). A two- to threefold di¡erence
in Kb values was obtained, certainly related to the
higher hydrophobicity of DIP as compared to RA-25
[19,30]. Interestingly, the binding constants of DIP
and RA-25 measured from the £uorescence spectra
in the membrane pellet are 0.8 þ 0.1 and 0.17 þ 0.03
(mg/ml)31, which correspond to a ratio similar to
that obtained in DPPC vesicles and equal to 4. How-
ever, this ratio is much smaller than the observed
IC50 ratio [6] and cannot explain by itself the two
orders of magnitude di¡erence in antioxidant activ-
ity.
The results showing that DIP is able to permeate
the membrane in a time dependent way with only a
partial inhibitory e¡ect against CuOOH-induced lip-
id peroxidation indicate that the binding to the mem-
brane is not su⁄cient either to avoid the radical spe-
cies formation by CuOOH or the propagation of this
process.
One general observation on iron-induced peroxida-
tion is the existence of a latent period (vt) until the
peroxidation reaction e¡ectively starts. This lag time
was explained as the period necessary for the radical
initiator formation prior to the membrane attack
[18]. Recently it was shown that the removal of either
Fe2 or Fe3 by adding a free iron chelator at the
end of the lag time resulted in inhibition of the lipid
peroxidation, supporting the hypothesis that an
Fe2^Fe3 complex is responsible for the iron-initi-
ated lipid peroxidation [9,37]. Indeed, our results also
have shown the e¡ectiveness of DIP, since independ-
ently of its addition during the observed vt or just
before it, and even after the beginning of V2, it was
able to inhibit the peroxidation process. So it is more
likely that DIP prevents both the radical formation
and the propagation reaction.
The lack of e¡ect of low concentrations of DIP on
the ¢rst peak of extra oxygen consumption (V1) was
a ¢rst indication that there was no direct interaction
of DIP with Fe2. Since DIP is a highly £uorescent
compound, its complexation with iron would result
in quenching of the £uorescence due to either heavy
metal or paramagnetic quenching. The possibility of
a direct interaction between DIP and Fe2 or Fe3
was investigated through the monitoring of the £uo-
rescence quenching by iron of a solution of DIP in
the reaction medium in the absence of mitochondria.
The direct experiment with ferrous sulfate quenching
was not quantitative due to the rapid oxidation of
iron (Fe2 to Fe3), which leads to a strong time-
dependent optical absorption of the solution prevent-
ing the analysis. Besides the iron oxidation, the solu-
tion becomes turbid, probably, due to precipitation
of iron hydroxide. We therefore made a control ex-
periment by incubating the solution of DIP with
FeSO4 and FeCl3 for 3 h followed by centrifugation.
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All of the DIP initially present in the solution re-
mained in the supernatant as judged by both optical
absorbance and £uorescence of the drug. This is also
an indication against the possibility of direct complex
formation of DIP with either Fe2 or Fe3, excluding
a chelation e¡ect.
Although this complex mechanism has not been
fully elucidated, our data indicate that binding to
the peripheral benzodiazepine receptor is not likely
to be important at the low concentrations under
which DIP completely inhibits the peroxidative proc-
ess. The partition of the drugs into the mitochondrial
membrane gave a better explanation to the e¡ects of
DIP on the propagation reactions of the lipid perox-
idation induced by Fe2. Moreover, the results pre-
sented in this work also con¢rm the radical scavenger
ability of DIP on Fe2-induced lipid peroxidation in
isolated mitochondria. It is possible that simplifying
the system, using mitoplasts instead of mitochondria,
will allow further experimental evidence to be ob-
tained, giving a more detailed understanding of the
mechanisms involved in the protection of peroxida-
tion by DIP. Such experiments are under way in our
laboratory.
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